Matthew Cooperberg, MD
Urology · San Francisco, CANPI 1841219326
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $61,261 of the $85,552 with a category attached, or 71.6%. It is spread thinly across 23 manufacturers, the largest accounting for just 19.7%. Reporting peaked in 2023 at $19,621 and has fallen 69.6% since, to $5,962 in 2025. Among urology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $919.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$17K
- Bayer$10K
- Astrazeneca UK Limited$8K
- Janssen Scientific Affairs, LLC$8K
- Astellas Pharma Global Development$7K
- Merck$7K
- plus $30K from 17 others
Across 21 payments — averaging $2080.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$44K
What the payments were for
- Consulting fees$61,26172%
- Speaking & faculty fees$18,23321%
- Travel & lodging$2,1723%
- Food & beverage$3,7874%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 13 | $16,893 |
| Bayer | 11 | $9,687 |
| Astrazeneca UK Limited | 7 | $7,770 |
| Janssen Scientific Affairs, LLC | 9 | $7,699 |
| Astellas Pharma Global Development | 2 | $6,750 |
| Merck | 8 | $6,687 |
| Progenics Pharmaceuticals, Inc. | 3 | $5,750 |
| Dendreon Pharmaceuticals LLC | 2 | $4,750 |
| Astellas Pharma US Inc | 3 | $4,204 |
| Blue Earth Diagnostics | 3 | $3,675 |
| AbbVie | 2 | $2,500 |
| GSK | 1 | $2,400 |
| Exelixis Inc. | 1 | $1,980 |
| Foundation Medicine, Inc. | 1 | $1,750 |
| EDAP Technomed Inc | 6 | $1,285 |
| Intuitive Surgical | 4 | $616 |
| Sanofi | 6 | $392 |
| Johnson & Johnson(2 entities) | 4 | $277 |
| Tempus AI, Inc | 2 | $216 |
| EMD Serono, Inc. | 1 | $147 |
| Teleflex LLC | 2 | $73 |
| Koelis Inc. | 1 | $30 |
| Integra Lifesciences Corporation | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTANDI$11,117
- TALZENNA$8,670
- Nubeqa$8,444
- PYLARIFY$5,750
- Erleada$4,914
- PROVENGE$4,725
- LYNPARZA$4,548
- POSLUMA$3,675
- Lupron Depot$2,500
- Cabometyx$1,980
- FOUNDATIONONE LIQUID CDX$1,750
- Da Vinci Surgical System$500
- FOCAL ONE$296
- NO PRODUCT DISCUSSED$287
- ORGOVYX$233
- BAVENCIO$147
How this compares
$85,552 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dutasteride | 13 | $679 |
| Tamsulosin Hcl | 38 | $436 |
| Finasteride | 24 | $372 |
Paid to pharmacies, not to this prescriber.
Other urology in San Francisco
- Marshall StollerSan Francisco$290K
- Stephen FreedlandWest Hollywood$1.9M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Steven WilsonIndio$1.1M
- Stuart HoldenLos Angeles$1.1M
- Elward CrawfordSan Diego$849K
- Edward UchioOrange$849K
- Victor ChingUpland$809K
- Jaime LandmanOrange$657K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.